1-10 of 10
Kirk Morris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An immunometabolic companion biomarker to enhance FDG-PET interpretation and guide frontline therapy in follicular lymphoma

Free
Ricky Nelles, Mark Meerson, Soi Law, Venkata Chikatamarla, Greg Hapgood, Tara Cochrane, Tsz Hung Tong, Jane Royle, Anna Johnston, Kate Manos, Yiyang Chen, Allison Barraclough, Chan Cheah, Eliza Hawkes, Georgina Hodges, Jake Shortt, Ross Salvaris, Elizabeth Goodall, Dipti Talaulikar, Judith Trotman, Kirk Morris, Naadir Gutta, Paolo Strati, Kirill Kriukov, Elizaveta Kozlova, Alisa Sadekova, Maria Sotova, Arina Tkachuk, Ekaterina Postovalova, Nathan Fowler, Maher Gandhi, Joshua Tobin
Journal: Blood
Blood (2025) 146 (Supplement 1): 5338.
https://doi.org/10.1182/blood-2025-5338
Published: 2025
Journal Articles

EZH2 and CREBBP mutation status identify a subset of patients who benefit from bendamustine- over CHOP/CVP-based immunochemotherapies in follicular lymphoma: Findings from the GALLIUM trial and validation in a large international cohort

Free
Verena Passerini, Vindi Jurinovic, Joshua Tobin, Kurt Bantilan, Victoria Shelton, Julia Richter, Jessica Okosun, Jude Fitzgibbon, Wolfram Klapper, Andrew Davies, Robert Marcus, Michael Herold, Wolfgang Hiddemann, Michael Unterhalt, Rajesh Detroja, Ricky Nelles, Patrick Lawrence, Greg Hapgood, Tara Cochrane, Anna Johnston, Jane Royle, Kate Manos, Allison Barraclough, Chan Cheah, Eliza Hawkes, Georgina Hodges, Jake Shortt, Dipti Talaulikar, Judith Trotman, Kirk Morris, Naadir Gutta, Alessia Bottos, Martin Dreyling, Maher Gandhi, Robert Kridel, Andrew Zelenetz, Eva Hoster, Oliver Weigert
Journal: Blood
Blood (2025) 146 (Supplement 1): 52.
https://doi.org/10.1182/blood-2025-52
Published: 2025
Journal Articles

Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Australasian Lymphoma Alliance

Free
Luani Barge, Joshua W.D. Tobin, Niamh Waters, Ross Salvaris, Sam Lai, Tessa Potezny, Helen Cashman, Caitlyn Nguyen-Ngo, Denise Lee, Costas K. Yannakou, Nada Hamad, Constantine S. Tam, Abir Bhattacharyya, Chan Y. Cheah, Kirk Morris, Eliza A. Hawkes, Greg Hapgood
Journal: Blood
Blood (2024) 144 (Supplement 1): 4416.
https://doi.org/10.1182/blood-2024-203146
Published: 2024
Journal Articles

Acute Leukaemia in Pregnancy: A Systematic Review of Maternal and Fetal Outcomes

Free
Wai Yee Jin, Giselle Kidson-Gerber, Antonia Shand, Antoinette Anazodo, Matthew Greenwood, Pietro R. Di Ciaccio, Shane Gangatharan, Ashley Kate McEwan, Kirk Morris, Caroline Wilson, Rachael Rodgers, Nada Hamad
Journal: Blood
Blood (2024) 144 (Supplement 1): 2428.
https://doi.org/10.1182/blood-2024-199449
Published: 2024
Journal Articles

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3 -ITD AML: a randomized, placebo-controlled study by the ALLG

Free
Clinical Trials & Observations
Sun Loo, Andrew W. Roberts, Natasha S. Anstee, Glen A. Kennedy, Simon He, Anthony P. Schwarer, Anoop K. Enjeti, James D’Rozario, Paula Marlton, Ian A. Bilmon, John Taper, Gavin Cull, Campbell Tiley, Emma Verner, Uwe Hahn, Devendra K. Hiwase, Harry J. Iland, Nick Murphy, Sundra Ramanathan, John Reynolds, Doen Ming Ong, Ing Soo Tiong, Meaghan Wall, Michael Murray, Tristan Rawling, Joanna Leadbetter, Leesa Rowley, Maya Latimer, Sam Yuen, Stephen B. Ting, Chun Yew Fong, Kirk Morris, Ashish Bajel, John F. Seymour, Mark J. Levis, Andrew H. Wei
Journal: Blood
Blood (2023) 142 (23): 1960–1971.
https://doi.org/10.1182/blood.2023020301
Published: 2023
Includes: Supplemental data
Journal Articles

High-Dose Cytarabine (HiDAC) Improves the Cure Rate of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Is It Better to be Given As Induction Therapy or As Consolidation Therapy?

Free
Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Joel Wight, MBBS, Kathryn Jackson, MBBS, Ashanka Mahilal Beligaswatte, BA, MBBS, MD FRACP, FRCPA, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Glen Kennedy, MBBS, FRACP, FRCPA, Louisa Martin, MBBS, Ian D. Lewis, MBBS PhD FRACP FRCPA, Devendra Hiwase, MBBS, FRACP, FRCPA, MD PhD, Daniela Zantomio, FRACP, FRCPA, MBBS, Simon Z. He, MBBS,FRACP,FRCPA, Andrew Grigg, MBBS, MD FRACP, FRCPA, Kirk Morris, FRACP FRCPA MBBS, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA, Paula Marlton, MBBS
Journal: Blood
Blood (2016) 128 (22): 3989.
https://doi.org/10.1182/blood.V128.22.3989.3989
Published: 2016
Journal Articles

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Free
Emad Uddin Abro, Kirk Morris, Georgina Hodges, Jason P Butler, Cameron Curley, Elango Subramonia Pillai, Glen A Kennedy
Journal: Blood
Blood (2013) 122 (21): 5017.
https://doi.org/10.1182/blood.V122.21.5017.5017
Published: 2013
Journal Articles

Results of a Prospective Phase II Randomized Study of Deferasirox (Exjade®) to Prevent Iatrogenic Iron Overload in Patients Undertaking Induction/Consolidation Chemotherapy for Acute Myeloid Leukaemia (HREC/10/QRBW/135)

Free
Glen A Kennedy, MBBS FRACP FRCPA, Kirk Morris, MBBS FRACP FRCPA, Elango Pillai, MBBS FRACP FRCPA, Cameron Curley, MBBS FRACP FRCPA, Jason P. Butler, MBBS, FRACP, FRCPA, MMSc, Simon Durrant
Journal: Blood
Blood (2012) 120 (21): 3577.
https://doi.org/10.1182/blood.V120.21.3577.3577
Published: 2012
Journal Articles

Outcomes and Prognostic Factors for Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

Free
Kathryn A Jackson, MBBS(Hons), Peter Mollee, Kirk Morris, MBBS FRACP FRCPA, Dwane L Jackson, MBBS, Peter Kruger, Kerenaftali Klein, Glen A Kennedy, MBBS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 3613.
https://doi.org/10.1182/blood.V120.21.3613.3613
Published: 2012
Journal Articles

Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly Patients

Free
Kathryn A Jackson, MBBS(Hon), Glen A Kennedy, MBBS FRACP FRCPA, Peter Mollee, Kirk Morris, MBBS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 4341.
https://doi.org/10.1182/blood.V120.21.4341.4341
Published: 2012